OTC Primatene contains epinephrine, while prescription albuterol (albuterol sulfate) is a short-acting beta agonist (SABA). Indications: Primatene is a bronchod ...
Objectives Continuous albuterol nebulization is generally administered at 2.5–20 mg/hr at most centers. We examined the effect of high-dose (75 or 150 mg/hr) albuterol on clinical variables in ...
Dan Dischner; Vice President - Corporate Communications; Amphastar Pharmaceuticals Inc. William Peters; Chief Financial Officer, Executive Vice President - Finance, ...
Albuterol 90mcg/inh; metered-dose aerosol. <4yrs: not recommended. ≥4yrs: 2 inh every 4–6 hrs as needed; 1 inh every 4 hrs may suffice. Exercise–induced bronchospasm: 2 inh 15 minutes before ...
Doctors said the extended period of dry air during this drought has triggered an increase in respiratory problems. "We're ...
Albuterol (as sulfate) 0.083%; soln for inh. Avoid excessive use. Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disease ...
Amphastar Pharmaceuticals Inc (AMPH) reports a 6% revenue increase, driven by record Primatene Mist sales, despite facing competitive and logistical hurdles.
Purpose: The effects of extreme temperatures on drug delivery of two albuterol sulfate hydrofluoroalkane, metered-dose inhalers (MDIs) were evaluated.Methods. Three Proventil HFA and three ...
Cipla , India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, ...
Discover the commercial and brand names of the generic drug Albuterol (Salbutamol). This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to ...
Although vapes have not been around long enough to yield long-term safety data, known risks associated with their ingredients ...
Cipla projects a mid-FY26 launch for Advair, while the release of Abraxane is contingent on regulatory clearance of the company's Goa facility. Respiratory drug Albuterol faces intensifying ...